30 min listen
Dr. Ronald Hirsch of R1RCM discusses new Alzheimer's drug Leqembi with HFMA's Nick Hut
Dr. Ronald Hirsch of R1RCM discusses new Alzheimer's drug Leqembi with HFMA's Nick Hut
ratings:
Length:
17 minutes
Released:
Jul 31, 2023
Format:
Podcast episode
Description
Dr. Ronald Hirsch of R1RCM discusses considerations around a new Alzheimer's drug with Senior Editor Nick Hut.
Mentioned in this episode:
CY 2024 Hospital Outpatient Prospective Payment System (OPPS) Policy Changes: Hospital Price Transparency Proposals (CMS-1786-P) | CMS
NCA - Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease (CAG-00431R) - Proposed Decision Memo (cms.gov)
Mentioned in this episode:
CY 2024 Hospital Outpatient Prospective Payment System (OPPS) Policy Changes: Hospital Price Transparency Proposals (CMS-1786-P) | CMS
NCA - Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease (CAG-00431R) - Proposed Decision Memo (cms.gov)
Released:
Jul 31, 2023
Format:
Podcast episode
Titles in the series (100)
Rep. Suzan Delbene's value-based payment legislation and Humana's population health milestone in Medicare Advantage markets: Rich Daly interviews Rep. Suzan Delbene about the Value in Health Care Act, proposed legislation that would make a series of hospital-supported changes to value-based programs operated by Medicare. Andrew Renda of Humana talks about how the company impro... by HFMA’s Voices in Healthcare Finance